atum logo
image/svg+xml

Tools and Solutions for
the Life Sciences

A Fully Integrated Ecosystem

Every path to discovery is different. We focus on your goals and work hand in hand with you to achieve them. Whether you need codon optimization, recombinant protein production, antibody humanization and engineering, or cell line development, ATUM delivers solutions to advance your research and speed your path to market.

ATUM's GPS platform - the key to your success

Our GPS® technology platform combines design of experiment (DoE) with machine learning tools, allowing us to optimize your biological systems for the properties that matter in the real world. The GPS technology provides an integrated bioengineering suite of solutions - from codon optimization to vector element selection algorithms - for the design and manufacture of optimized genes, vectors, enzymes, antibodies and cell lines with application across the Life Science spectrum.

A Fully Integrated Ecosystem

Every path to discovery is different. We focus on your goals and work hand in hand with you to achieve them. Whether you need codon optimization, recombinant protein production, antibody humanization and engineering, or cell line development, ATUM delivers solutions to advance your research and speed your path to market.

ATUM's GPS platform - the key to your success

Our GPS® technology platform combines design of experiment (DoE) with machine learning tools, allowing us to optimize your biological systems for the properties that matter in the real world. The GPS technology provides an integrated bioengineering suite of solutions - from codon optimization to vector element selection algorithms - for the design and manufacture of optimized genes, vectors, enzymes, antibodies and cell lines with application across the Life Science spectrum.

Expert
Guidance

We think of projects more as a collaboration than services. We aim to combine your expertise with our expertise so that together we succeed. Whether you are selecting the best vector and codon optimization for a gene to express in your own lab, or you want us to take you from hybridoma sequence to high producing cell line, our team is ready to help.

Call

Corporate Headquarters
(Newark, California)
+1 650 853 8347

Email

We generally reply within a few hours.

info@atum.bio

ATUM
in the World

May 17-19 2022

BPI Europe 2022

Vienna, Austria
ATUM's Oren Beske will present on Tues May 17 at 9:30-10:00 and exhibit at booth #106
May 22-27 2022

Enzyme Engineering XXVI

Dallas/Fort Worth,TX
ATUM's Sridhar Govindarajan will present Monday May 23 at 10:30 am and chair session, Thursday May 26 at 10:30am
June 07-09 2022

Antibody Engineering & Therapeutics Europe

Amsterdam, The Netherlands
ATUM will present on Thursday June 9 7:30-8:00 CEST and exhibit at booth #29
June 13-16 2022

BIO International Convention

San Diego, CA
ATUM will attend
June 26-29 2022

ESACT

Lisbon, Portugal
ATUM will attend and exhibit at booth #82
July 10-15 2022

GRC Biocatalysis

Manchester, NH
ATUM will attend
September 11-15 2022

16th PEACe

Sitges, Spain
ATUM will present and exhibit, time TBA
September 28-29 2022

Bioproduction vol.10 Continuum for Biologics

Charleroi, Belgium
ATUM will exhibit
November 14-16 2022

PEGS Europe 2022

Barcelona, Spain
ATUM will present and exhibit at booth #216, time TBA
December 04-08 2022

Antibody Engineering & Therapeutics

San Diego, CA
ATUM will present, time TBA and exhibit at booth #404
2021-12-01

Will we be protected from COVID-19’s omicron variant? Bay Area researchers sprint to find out

2021-03-19

Inom en timme hade vi tio rush-orders

2021-03-19

Fighting for Our Lives

2020-07-26

Biotech firm rebounds to combat coronavirus

2020-07-22

Big Heroes of Small Business: This Biotech Business Won't Let Cost Get in the Way of a Covid Cure

2022-04-26

ATUM Launches cGMP-Compliant Master Cell Bank Production Services

2022-04-20

ATUM Partners with TrioBio to Deliver Leap-In Transposase®-Based Bioengineering Solutions to the Chinese Pharmaceutical Market

2020-10-22

IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access

2020-10-14

Rentschler Biopharma and ATUM announce Leap-In Transposase® licensing agreement for development of robust manufacturing processes for complex therapeutic proteins

2020-06-15

ATUM and Phylex BioSciences Collaborate to Accelerate the Development of a Universal SARS Coronavirus Vaccine

`